Literature DB >> 18704112

Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action.

Martin Rostami-Yazdi, Bernd Clement, Thomas J Schmidt, Daniel Schinor, Ulrich Mrowietz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18704112     DOI： 10.1038/jid.2008.197

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  23 in total

1.  Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.

Authors:  Manuj Ahuja; Navneet Ammal Kaidery; Lichuan Yang; Noel Calingasan; Natalya Smirnova; Arsen Gaisin; Irina N Gaisina; Irina Gazaryan; Dmitry M Hushpulian; Ismail Kaddour-Djebbar; Wendy B Bollag; John C Morgan; Rajiv R Ratan; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  J Neurosci       Date:  2016-06-08       Impact factor: 6.167

2.  Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.

Authors:  Michael D Kornberg; Pavan Bhargava; Paul M Kim; Vasanta Putluri; Adele M Snowman; Nagireddy Putluri; Peter A Calabresi; Solomon H Snyder
Journal:  Science       Date:  2018-03-29       Impact factor: 47.728

Review 3.  Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

4.  The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes.

Authors:  Inas Helwa; Ravi Patel; Peter Karempelis; Ismail Kaddour-Djebbar; Vivek Choudhary; Wendy B Bollag
Journal:  J Pharmacol Exp Ther       Date:  2014-10-20       Impact factor: 4.030

5.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.

Authors:  Henrik Wilms; Jobst Sievers; Uta Rickert; Martin Rostami-Yazdi; Ulrich Mrowietz; Ralph Lucius
Journal:  J Neuroinflammation       Date:  2010-05-19       Impact factor: 8.322

6.  Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.

Authors:  Jan P Nicolay; Karin Müller-Decker; Anne Schroeder; Markus Brechmann; Markus Möbs; Cyrill Géraud; Chalid Assaf; Sergij Goerdt; Peter H Krammer; Karsten Gülow
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

Review 7.  Therapeutic decisions in multiple sclerosis: moving beyond efficacy.

Authors:  Wolfgang Brück; Raff Gold; Brett T Lund; Celia Oreja-Guevara; Alexandre Prat; Collin M Spencer; Lawrence Steinman; Mar Tintoré; Timothy L Vollmer; Martin S Weber; Leslie P Weiner; Tjalf Ziemssen; Scott S Zamvil
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

8.  Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease.

Authors:  Isabel Lastres-Becker; Angel J García-Yagüe; Robert H Scannevin; María J Casarejos; Sebastian Kügler; Alberto Rábano; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2016-04-27       Impact factor: 8.401

Review 9.  Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 10.  Emerging Therapeutic Applications for Fumarates.

Authors:  Ayla Hoogendoorn; Thomas D Avery; Jiahe Li; Christina Bursill; Andrew Abell; Peter M Grace
Journal:  Trends Pharmacol Sci       Date:  2021-02-19       Impact factor: 14.819
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.